Verchere CB - Search Results

1

Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro.

Verchere CB, D'Alessio DA, Palmiter RD, Kahn SE. Verchere CB, et al. Diabetologia. 1994 Jul;37(7):725-8. doi: 10.1007/BF00417699. Diabetologia. 1994. PMID: 7958546

2

Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse.

D'Alessio DA, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD, Ensinck JW. D'Alessio DA, et al. Among authors: verchere cb. Diabetes. 1994 Dec;43(12):1457-61. doi: 10.2337/diab.43.12.1457. Diabetes. 1994. PMID: 7958499

3

Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway.

Kahn SE, Verchere CB, D'Alessio DA, Cook DL, Fujimoto WY. Kahn SE, et al. Among authors: verchere cb. Diabetologia. 1993 Jun;36(6):570-3. doi: 10.1007/BF02743276. Diabetologia. 1993. PMID: 8335181

4

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE. Verchere CB, et al. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3492-6. doi: 10.1073/pnas.93.8.3492. Proc Natl Acad Sci U S A. 1996. PMID: 8622964 Free PMC article.

5

Des-(27-31)C-peptide. A novel secretory product of the rat pancreatic beta cell produced by truncation of proinsulin connecting peptide in secretory granules.

Verchere CB, Paoletta M, Neerman-Arbez M, Rose K, Irminger JC, Gingerich RL, Kahn SE, Halban PA. Verchere CB, et al. J Biol Chem. 1996 Nov 1;271(44):27475-81. doi: 10.1074/jbc.271.44.27475. J Biol Chem. 1996. PMID: 8910330 Free article.

6

Evidence that galanin is a parasympathetic, rather than a sympathetic, neurotransmitter in the baboon pancreas.

Verchere CB, Kowalyk S, Koerker DJ, Baskin DG, Taborsky GJ Jr. Verchere CB, et al. Regul Pept. 1996 Dec 3;67(2):93-101. doi: 10.1016/s0167-0115(96)00120-6. Regul Pept. 1996. PMID: 8958579

7

Transgenic overproduction of islet amyloid polypeptide (amylin) is not sufficient for islet amyloid formation.

Verchere CB, D'Alessio DA, Wang S, Andrikopoulos S, Kahn SE. Verchere CB, et al. Horm Metab Res. 1997 Jun;29(6):311-6. doi: 10.1055/s-2007-979042. Horm Metab Res. 1997. PMID: 9230354 Review.

8

Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.

Kahn SE, Verchere CB, Andrikopoulos S, Asberry PJ, Leonetti DL, Wahl PW, Boyko EJ, Schwartz RS, Newell-Morris L, Fujimoto WY. Kahn SE, et al. Among authors: verchere cb. Diabetes. 1998 Apr;47(4):640-5. doi: 10.2337/diabetes.47.4.640. Diabetes. 1998. PMID: 9568698

9

Human aging is associated with parallel reductions in insulin and amylin release.

Dechenes CJ, Verchere CB, Andrikopoulos S, Kahn SE. Dechenes CJ, et al. Among authors: verchere cb. Am J Physiol. 1998 Nov;275(5):E785-91. doi: 10.1152/ajpendo.1998.275.5.E785. Am J Physiol. 1998. PMID: 9814997

10

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.

Kahn SE, Andrikopoulos S, Verchere CB. Kahn SE, et al. Among authors: verchere cb. Diabetes. 1999 Feb;48(2):241-53. doi: 10.2337/diabetes.48.2.241. Diabetes. 1999. PMID: 10334297 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters